News & Announcements Press Release – Black Diamond Therapeutics Closes $85 Million Series C Financing Continue Reading
News & Announcements Press Release – Black Diamond Therapeutics to Present Preclinical Data on its Lead Product Candidate BDTX-189 at the European Society for Medical Oncology 2019 Continue Reading
News & Announcements Press Release – Black Diamond Therapeutics Names Christopher Roberts, Ph.D., as Chief Scientific Officer Continue Reading
News & Announcements Press Release – Black Diamond Therapeutics Appoints Thomas Leggett as Chief Financial Officer Continue Reading
News & Announcements Press Release – Black Diamond Therapeutics Appoints Industry Veteran as Chief Operating Officer and General Counsel Continue Reading
News & Announcements Press Release – Black Diamond Therapeutics Presents Data From its Program Targeting Oncogenic Allosteric Mutations in EGFR for Glioblastoma as Late Breaker at the American Association for Cancer Research (AACR) Annual Meeting Continue Reading
News & Announcements Press Release – Black Diamond Therapeutics Closes $85 Million Series B Financing Continue Reading
News & Announcements Press Release – Versant Ventures Launches Black Diamond Therapeutics Continue Reading
